The ProLung Test™
The only predictive analytics technology available for the lung*
The ProLung Test is a cutting-edge predictive analytics technology for the risk stratification of indeterminate pulmonary nodules that can lead to lung cancer. Our patented solution uses precision proprietary volume-averaging Electrical Impedance Analytics (EIA) technology to non-invasively measure the difference in conductivity between malignant and benign lung tissue. The patient’s test results are analyzed to produce a personalized and predictive risk score indicating the likelihood of malignancy.